Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

NCT00840853 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Non Hodgkin's Lymphoma

Interventions

GENETIC: CD19CAR/virus specific T cells
DRUG: Benadryl and Tylenol

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]